(19)
(11) EP 1 372 392 A1

(12)

(43) Date of publication:
02.01.2004 Bulletin 2004/01

(21) Application number: 02721544.1

(22) Date of filing: 22.03.2002
(51) International Patent Classification (IPC)7A01N 43/04, A61K 31/715, A61K 9/14, A61K 9/20
(86) International application number:
PCT/US2002/008914
(87) International publication number:
WO 2002/076211 (03.10.2002 Gazette 2002/40)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 26.03.2001 US 278606 P

(71) Applicant: SMITHKLINE BEECHAM CORPORATION
PhiladelphiaPennsylvania 19103 (US)

(72) Inventors:
  • LIU, John
    Parsippany, NJ 07054 (US)
  • LECH, Stanley, J.
    Parsippany, NJ 07054 (US)
  • PLATCOW, Stuart
    Parsippany, NJ 07054 (US)

(74) Representative: Morris, Miriam Elizabeth et al
GlaxoSmithKlineCorporate Intellectual Property980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) NICOTINE-CONTAINING ORAL DOSAGE FORM